Jason Lettmann - Profile and Investment Details

Investor Profile

Jason Lettmann is a Venture Capital, Investor based in Boulder, Colorado, United States with a diverse investment portfolio that includes companies such as Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Tarsus Medical, Locanabio, Claret Medical, FIRE1 Foundry, Relievant Medsystems, Carrick Therapeutics, Catabasis Pharmaceuticals, Flex Pharma, Second Genome, Inc., Disarm Therapeutics, Relievant Medsystems, Inc., Cyteir Therapeutics, Promedior, Inc., Ardian, Cerevance, Vapotherm, Nimbus Therapeutics, Catamaran Bio, Willow, ALX OncologyEBR Systems, Nimbus Apollo, Tallac Therapeutics, Evalve, Nuvaira, Atsena Therapeutics, Cala Health, Second Genome, Tizona Therapeutics, Bold Penguin, Earlens Corporation, Ra Pharmaceuticals, FIRE1, . Over time, Jason Lettmann has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jason Lettmann is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Wellness, Women Founded, Life Science, Engineering, Information Technology (IT), Biotechnology, Innovation, Clinical Trials, Research, Innovation Management, Medical, B2B, Therapeutics, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Jason Lettmann, as their portfolio suggests a familiarity and interest in this area.

Understanding Jason Lettmann’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.